Meningitis Substantial Contributor to Mortality in Children Younger Than 5 Years
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Meningitis is a substantial contributor to mortality in children younger than 5 years of age in low- and middle-income countries, according to a study published online Nov. 19 in the Journal of Infection.
Sana Mahtab, from the University of the Witwatersrand in Johannesburg, and colleagues assessed the contribution of meningitis to mortality and identified causative pathogens in children younger than 5 years in an observational study. Deaths were analyzed in live-born children younger than 5 years of age that occurred between Dec. 16, 2016, and Dec. 31, 2023, in six sub-Saharan African countries and Bangladesh.
The researchers found that for 7.0 percent of deaths (270/3,857), meningitis was the causal pathway, and meningitis was considered the underlying condition in 4.8 percent (13/270) of these deaths. Neonates and infants/children accounted for 65.9 and 34.1 percent of the 270 deaths, respectively. Among neonatal meningitis deaths, 55.6 percent occurred ≥72 hours post-hospital admission; Acinetobacter baumannii and Klebsiella pneumoniae were common pathogens (49.5 and 40.4 percent, respectively). Overall, 44 percent of neonatal meningitis deaths were community associated, mainly due to K. pneumoniae and Escherichia coli (35.4 and 13.9 percent, respectively). Of the infant and child meningitis deaths, 43.5 percent occurred ≥72 hours post-hospital admission; common pathogens were K. pneumoniae and A. baumannii (42.5 and 17.5 percent, respectively). Streptococcus pneumoniae and K. pneumoniae were common pathogens (34.6 and 19.2 percent, respectively) among community-associated meningitis deaths in infants and children.
"Our findings indicate that meningitis remains a leading cause of mortality among children under 5, with many cases going undiagnosed before death, highlighting the urgent need for improved diagnostic and treatment methods," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-28 06:00
Read more
- ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria
- Young Adults Born Preterm Face Economic and Educational Challenges
- 2021 to 2022 Saw Decline in Abortions in the United States
- Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier
- 24.3 Percent of U.S. Adults Had Chronic Pain in Past Three Months in 2023
- American College of Allergy, Asthma & Immunology, Oct. 24-28
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions